- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04705805
Self-assessment of Olfactory Disorders for French Speaking Patients (VIF-DOR)
Validation of Two Self-questinnaires on Olfactory Disorders for French Speaking Patients: the Self-evaluation of Olfactory Capacities and Quality of Life Questionnaires
Sense of smell disorders are common and are said to affect up to 20% of the general population. They are often disabling and have a real impact on the quality of life. Smell disorders are most often assessed using a visual analogue scale and more rarely with objective tests (Sniffing Stick Test). Many ENT units do not have these objective tests because they are time-consuming and are not covered by health insurance.
Some teams, such as that of Dr Thomas Hummel of the Carl Gustav Carus University Clinic in Dresden Germany, have developed self-assessment questionnaires for the sense of smell in order to improve the overall care of patients with olfactory disorders. Two of these self-questionnaires seem to us to be particularly relevant for use in everyday practice.
Since then, these questionnaires have already been validated in different languages (English, Chinese, Korean...), but have never been translated and validated in French. Translating and validating these questionnaires into French would make it possible to improve the management and follow-up of French patients with olfactory disorders and to assess the impact of loss of smell on their quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Marion RENAUD
- Phone Number: +33 3 88 12 61 89
- Email: Marion.renaud@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67098
- Les Hôpitaux Universitaires de Strasbourg
-
Contact:
- Marion RENAUD
- Phone Number: +33 3 88 12 61 89
- Email: Marion.renaud@chru-strasbourg.fr
-
Principal Investigator:
- Marion RENAUD
-
Sub-Investigator:
- Christian DEBRY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Case patients with acquired olfactory disorders will be selected from the ENT primary care clinic of Strasbourg University Hospital.
Control patient without olfactory disorders are treated for another ENT pathology in the ENT primary care clinic of Strasbourg University Hospital.
Description
Inclusion Criteria:
- Patient > 18 years old
- Patient affiliated to a sickness insurance social protection scheme, beneficiary or rightful claimant
- Patient who has not expressed his or her opposition to the collection and processing of his or her data for research purposes after the investigator has provided informed information.
- Patient presenting an olfactory dysfunction of any acquired aetiology that has been evolving for at least 3 months without total recovery (case group).
- Patient with no sense of smell problems followed up in ENT for another pathology that does not affect the sense of smell (control group).
Exclusion Criteria:
- Patient in an emergency or life-threatening situation
- Patient under judicial protection
- Patient under guardianship or trusteeship
- Inability to provide informed information to the patient (patient does not speak or understand French)
- Patient with congenital syndromic or non-syndromic congenital anosmia
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Case
Patient presenting an olfactory dysfunction of any acquired aetiology that has been evolving for at least 3 months without total recovery.
|
|
Control
Patient with no sense of smell problems followed up in ENT for another pathology that does not affect the sense of smell
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reliability of the self-assessment questionnaire
Time Frame: 3 months
|
To assess the reliability of the self-assessment questionnaire of his olfactory capacities (Self-MOQ) in French in patients presenting an olfactory dysfunction of any acquired etiology for more than 3 months using a test-retest trial.
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7917
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Rhinosinusitis
-
Unity Health TorontoCompletedChronic RhinosinusitisCanada
-
University of MiamiCompleted
-
Medtronic Surgical TechnologiesCompleted
-
University of MichiganNeilMed PharmaceuticalsCompletedChronic RhinosinusitisUnited States
-
Odense University HospitalCompleted
-
Taichung Veterans General HospitalCompletedPostoperative Care | Chronic RhinosinusitisTaiwan
-
Christiane HaaseActive, not recruitingAsthma | Chronic Rhinosinusitis (Diagnosis) | Chronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal PolypsDenmark
-
Washington University School of MedicineCompletedChronic Rhinosinusitis (Diagnosis) | Allergic Rhinosinusitis | Chronic Eosinophilic RhinosinusitisUnited States
-
Icahn School of Medicine at Mount SinaiTivic Health SystemsRecruiting
Clinical Trials on Self-assessment of olfactory disorders through two questionnaires.
-
Fondation Ophtalmologique Adolphe de RothschildWithdrawn
-
University Medical Centre MariborFaculty of Medicine, University of MariborCompletedSelf-Injurious Behavior | Self Injurious Behavior Without Suicidal Intent
-
University of California, San FranciscoAmerican Society of Clinical Oncology; Conquer Cancer FoundationRecruitingGynecologic Cancer | Malignant Female Reproductive System Neoplasm | Gynecologic NeoplasmUnited States
-
Centre Francois BaclesseARCAGY/ GINECO GROUPActive, not recruitingGerm Cell Tumor | Sex Cord Stromal Tumor | Malignant Non-epithelial Ovarian TumorsFrance
-
Massachusetts General HospitalEnrolling by invitation
-
University Hospital, MontpellierUniversity Hospital, Geneva; Institut National de la Santé Et de la Recherche...Terminated
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; St. Jude Children's Research HospitalActive, not recruitingAdult Survivors of Childhood LeukemiaUnited States
-
Poitiers University HospitalCompletedPostnatal DepressionFrance
-
Case Comprehensive Cancer CenterTerminatedAny Cancer DiagnosisUnited States
-
M.D. Anderson Cancer CenterWithdrawnSmoking CessationUnited States